Assessing the analgesic efficacy of oral epigallocatechin-3-gallate on epidural catheter analgesia in patients after surgical stabilisation of multiple rib fractures: a prospective double-blind, placebo-controlled clinical trial

Context Thoracic trauma results in multiple rib fractures (MRF), and surgical stabilisation of rib fractures (SSRF) can relieve fracture pain. Epigallocatechin-3-gallate (EGCG) is reported to exhibit beneficial effects in bone-related metabolic and differentiation processes. Objective To study the clinical effect of EGCG on regional analgesia for pain relief in MRF patients after SSRF. Materials and methods Ninety-seven MRF patients (61 males, 36 females) who were on epidural catheter analgesia after SSRF were recruited. They were randomly divided into: oral EGCG 100 mg (oral grade) twice daily for 10 days and placebo groups. Pain scores, incentive spirometry (IS) volumes, respiratory rate and oxygen saturation (SpO(2)) were assessed day 10 after SSRF. Results Comparing results from the placebo and EGCG group, in the 10-day intervention course, oral EGCG reduced pain score (8 at base line vs. 4 at end of intervention in EGCG group,p < 0.05; 4 in EGCG group vs. 6 in placebo group at end of intervention,p < 0.05), improved IS volume (713 at base line vs. 1072 at end of intervention in EGCG group,p < 0.05; 1072 in EGCG group vs. 953 in placebo group at end of intervention,p < 0.05) and respiratory rate (24 at base line vs. 15 at end of intervention in EGCG group,p < 0.05; 15 in EGCG group vs. 19 in placebo group at end of intervention,p < 0.05). However, no further enhancing effect on SpO(2)was observed in the EGCG group (0.98 in EGCG group vs. 0.98 in placebo group at end of intervention,p > 0.05). Discussion and conclusions Although the study is limited by a relatively small sample size and lack of serum factor analysis, the key results and the study design, for the first time, nevertheless pave the way for trials with larger number of patients to understand the effect of EGCG in MRF patients that are undergoing SSRF.